Vedolizumab in the treatment of chronic, antibiotic‐dependent or refractory pouchitis
Florian Bär(University of Lübeck), Ulf Helwig(Clinical Research Center Kiel), Klaus Fellermann(Apple (Israel)), Stefan Schreiber(Christian-Albrechts-Universität zu Kiel), Niels Teich(Leipzig University), Jürgen Büning(University Hospital Schleswig-Holstein), Andreas Stallmach(Jena University Hospital), Renate Schmelz(University Hospital Carl Gustav Carus), N.A. Dietrich(University Hospital Schleswig-Holstein), Jens Walldorf(Martin Luther University Halle-Wittenberg), T Krause, Tanja Kühbacher(University Hospital Schleswig-Holstein), Carsten Büning(Charité - Universitätsmedizin Berlin)
Cited by 83
Related Papers
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
|Nature Genetics|2010|2.6k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways
|Nature Genetics|2009|1.4k